Reviewing the state of biotech with John Maraganore
- blonca9
- Dec 29, 2023
- 1 min read
John Maraganore shares his thoughts about biotech's big achievements in 2023, the financing environment, science, and hurdles to watch in 2024, HELIOS-B, and more.
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.